Compare Procter & Gamble Health with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DR. REDDYS LAB - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DR. REDDYS LAB PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
 
P/E (TTM) x 52.8 17.9 294.3% View Chart
P/BV x 4.6 3.4 133.7% View Chart
Dividend Yield % 10.3 0.7 1,501.0%  

Financials

 PROCTER & GAMBLE HEALTH   DR. REDDYS LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
DR. REDDYS LAB
Mar-19
PROCTER & GAMBLE HEALTH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,5492,875 123.4%   
Low Rs1,3011,888 68.9%   
Sales per share (Unadj.) Rs511.4930.2 55.0%  
Earnings per share (Unadj.) Rs61.3117.4 52.2%  
Cash flow per share (Unadj.) Rs74.0185.8 39.8%  
Dividends per share (Unadj.) Rs440.0020.00 2,200.0%  
Dividend yield (eoy) %18.10.8 2,160.4%  
Book value per share (Unadj.) Rs927.8844.4 109.9%  
Shares outstanding (eoy) m16.60166.07 10.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.72.6 185.2%   
Avg P/E ratio x39.620.3 195.1%  
P/CF ratio (eoy) x32.812.8 255.6%  
Price / Book Value ratio x2.62.8 92.7%  
Dividend payout %717.917.0 4,214.9%   
Avg Mkt Cap Rs m40,257395,496 10.2%   
No. of employees `0001.122.0 5.2%   
Total wages/salary Rs m1,31333,562 3.9%   
Avg. sales/employee Rs Th7,486.77,032.8 106.5%   
Avg. wages/employee Rs Th1,157.61,527.9 75.8%   
Avg. net profit/employee Rs Th897.2887.7 101.1%   
INCOME DATA
Net Sales Rs m8,490154,482 5.5%  
Other income Rs m2443,375 7.2%   
Total revenues Rs m8,734157,857 5.5%   
Gross profit Rs m1,48231,782 4.7%  
Depreciation Rs m21111,348 1.9%   
Interest Rs m0889 0.0%   
Profit before tax Rs m1,51422,920 6.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5633,858 14.6%   
Profit after tax Rs m1,01719,500 5.2%  
Gross profit margin %17.520.6 84.8%  
Effective tax rate %37.116.8 220.7%   
Net profit margin %12.012.6 94.9%  
BALANCE SHEET DATA
Current assets Rs m15,343111,101 13.8%   
Current liabilities Rs m1,96058,973 3.3%   
Net working cap to sales %157.633.7 467.1%  
Current ratio x7.81.9 415.5%  
Inventory Days Days4979 61.4%  
Debtors Days Days2894 30.2%  
Net fixed assets Rs m1,209101,245 1.2%   
Share capital Rs m166830 20.0%   
"Free" reserves Rs m15,235139,406 10.9%   
Net worth Rs m15,401140,236 11.0%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m17,595224,656 7.8%  
Interest coverage xNM26.8-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.50.7 70.2%   
Return on assets %5.89.1 63.7%  
Return on equity %6.613.9 47.5%  
Return on capital %10.314.9 68.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,63688,673 1.8%   
Fx outflow Rs m4,36819,104 22.9%   
Net fx Rs m-2,73269,569 -3.9%   
CASH FLOW
From Operations Rs m-1,30428,704 -4.5%  
From Investments Rs m12,697-7,727 -164.3%  
From Financial Activity Rs m-301-21,326 1.4%  
Net Cashflow Rs m11,093-314 -3,532.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.4 337.0%  
FIIs % 1.0 35.3 2.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 29.1 15.3 190.2%  
Shareholders   28,591 75,885 37.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Auto and Energy Stocks Witness Buying(Closing)

Indian share markets ended their volatile trading day on a flattish note. At the closing bell, the BSE Sensex stood higher by 42 points (up 0.1%).

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

This PSU Turned into a Rare 100 Bagger. Others May Follow.(The 5 Minute Wrapup)

Nov 27, 2019

The lowest hanging fruit for government to raise capital would be to sell off stakes in non-critical PSUs.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Dec 9, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS